Innovax-ILT
avian infectious laryngotracheitis and Marek’s disease vaccine (live)
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Innovax-ILT. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Innovax-ILT.
For practical information about using Innovax-ILT, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Innovax-ILT
|
Agency product number |
EMEA/V/C/003869
|
Active substance |
Cell-associated live recombinant turkey herpesvirus (strain HVT/ILT-138), expressing the glycoproteins gD and gI of infectious laryngotracheitis virus
|
International non-proprietary name (INN) or common name |
avian infectious laryngotracheitis and Marek’s disease vaccine (live)
|
Species |
Chicken
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QI01AD03
|
Publication details | |
---|---|
Marketing-authorisation holder |
Intervet International B.V.
|
Revision |
5
|
Date of issue of marketing authorisation valid throughout the European Union |
03/07/2015
|
Contact address |
Wim de Körverstraat 35 |
Product information
09/09/2021 Innovax-ILT - EMEA/V/C/003869 - WS2102/G
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Immunologicals for aves
-
Live viral vaccines
Therapeutic indication
For active immunisation of one-day-old chicks to reduce mortality, clinical signs and lesions due to infection with avian infectious laryngotracheitis (ILT) virus and Marek’s disease (MD) virus.